A heart drug failure, RevMed's pancreatic cancer drug approved, and more biotech news from The Readout

A heart drug failure, RevMed's pancreatic cancer drug approved, and more biotech news from The Readout

Moderna’s upsized note offering quickly followed a big win in a crucial study. Elsewhere, a biotech’s shares tumbled after study data were “inadvertently” published ahead of a…